GPR68 and acute respiratory distress syndrome: Another major focus of this study was to evaluate the effects of the new GPR68 inhibitor on pulmonary EC dysfunction and ALI caused by endotoxin LPS in more clinically relevant scenario where therapeutic interventions are performed for pre-existing disease state.